Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy

Abstract Breast cancer therapy has significantly advanced by targeting the programmed cell death-ligand 1/programmed cell death-1 (PD-L1/PD-1) pathway. BMS-202 (a smallmolecule PD-L1 inhibitor) induces PD-L1 dimerization to block PD-1/PD-L1 interactions, allowing the T-cell-mediated immune response...

Full description

Bibliographic Details

Published in:	Journal of Nanobiotechnology
Main Authors:	Bowen Zeng, Lina Pian, Yanhong Liu, Shuangqing Wang, Nuoya Wang, Chao Liu, Hao Wu, Hongshuang Wan, Liqing Chen, Wei Huang, Zhonggao Gao, Xuezhe Yin, Mingji Jin
Format:	Article
Language:	English
Published:	BMC 2024-09-01
Subjects:	Breast cancer Photodynamic therapy Immunotherapy Immune checkpoint blockade Folate receptor tumor targeting
Online Access:	https://doi.org/10.1186/s12951-024-02838-1